Drugs / Infanrix® -IPV+Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00287092 Comparator | Feb 2006 → May 2007 | diphtheria, haemophilus infectious disease, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix -IPV+Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00287092 ↗ |
| Route | Intramuscular | “0.5 mL, IM” NCT00287092 ↗ |